Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 29 Dec 2021 for Dicerna Pharmaceuticals Inc, €262k.
Insider track record
Disclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Douglas W. Pagan: trading record in brief
Douglas W. Pagan (finance chief) discloses dealings in 3 companies, chiefly Paratek Pharmaceuticals, Inc., Dicerna Pharmaceuticals Inc and Alaunos Therapeutics, Inc. Between 4 February 2015 and 28 December 2021, the trades on record add up to 37 filings.
No open-market purchase appears, only 14 sales worth €595k. Outside the open market, there are 16 share grants and 2 option exercises.
The newest entry dates from 29 December 2021: a transaction of €262k, in Dicerna Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Douglas W. Pagan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
7,775 shares@ US$38.25100.0% of flowCommon StockSEC:0001399529-21-000203:0
2,050 sharesCommon StockSEC:0001399529-21-000178:0
6,825 sharesCommon StockSEC:0001399529-21-000121:0
24,000 sharesCommon StockSEC:0000904454-16-000924:0
35,000 sharesCommon StockSEC:0000904454-16-000916:0
5 of 5 declarations
